Local Determinants of Thrombus Formation Following Sirolimus-Eluting Stent Implantation Assessed by Optical Coherence Tomography

JACC: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 459-466

  Otake, Hiromasa ^a   Shite, Junya ^a   Ako, Junya ^b   Shinke, Toshiro ^a   Tanino, Yusuke ^a   Ogasawara, Daisuke ^a   Sawada, Takahiro ^a   Miyoshi, Naoki ^a   Kato, Hiroki ^a   Koo, Bon Kwon ^b   Honda, Yasuhiro ^b   Fitzgerald, Peter J ^b   Hirata, Ken ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b STANFORD UNIVERSITY   (United States)

Author keywords

optical coherence tomography; sirolimus eluting stents; thrombus

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RAPAMYCIN; TICLOPIDINE; ANTITHROMBOCYTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

AGED; ANGIOSCOPY; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; EQUIPMENT DESIGN; FEMALE; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; STENT THROMBOSIS; THROMBOGENESIS; ANALOGS AND DERIVATIVES; CORONARY RESTENOSIS; CORONARY THROMBOSIS; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; JAPAN; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MALE; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; TICLOPIDINE; TOMOGRAPHY, OPTICAL COHERENCE; ULTRASONOGRAPHY, INTERVENTIONAL; ANGIOPLASTY, BALLOON, CORONARY;

EID: 65549111877     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.03.003     Document Type: Article

References (22)

1. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
2. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
3. Kotani J., Awata M., Nanto S., et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47 (2006) 2108-2111
4. Awata M., Kotani J., Uematsu M., et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 116 (2007) 910-916
5. Airoldi F., Colombo A., Morici N., et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 116 (2007) 745-754
6. Lambert T.L., Dev V., Rechavia E., Forrester J.S., Litvack F., and Eigler N.L. Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin. Circulation 90 (1994) 1003-1011
7. Hwang C.W., Wu D., and Edelman E.R. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104 (2001) 600-605
8. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
9. Matsumoto D., Shite J., Shinke T., et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28 (2007) 961-967
10. Kume T., Akasaka T., Kawamoto T., et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 97 (2006) 1713-1717
11. Jang I.K., Tearney G.J., MacNeill B., et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 111 (2005) 1551-1555
12. Fujii K., Carlier S.G., Mintz G.S., et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
13. Laarman G.J., Suttorp M.J., Dirksen M.T., et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 355 (2006) 1105-1113
14. Moreno R., Fernandez C., Hernandez R., et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
15. Schampaert E., Moses J.W., Schofer J., et al., SIRIUS, E-SIRIUS, and C-SIRIUS Investigators. Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. Am J Cardiol 98 (2006) 36-41
16. Takano M., Yamamoto M., Xie Y., et al. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy. Heart 93 (2007) 1533-1536
17. Farb A., Burke A.P., Kolodgie F.D., and Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-1706
18. Finn A.V., Kolodgie F.D., Harnek J., et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112 (2005) 270-278
19. Kaneda H., Ako J., Honda Y., et al. Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation. Am J Cardiol 96 (2005) 1404-1407
20. Yabushita H., Bouma B.E., Houser S.L., et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 106 (2002) 1640-1645
21. Kubo T., Imanishi T., Takarada S., et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 50 (2007) 933-939
22. Sonoda S., Morino Y., Ako J., et al., SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 43 (2004) 1959-1963